This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.


Ready-to-use Radiopharmaceutical for Diagnosis & Staging of Neuroendocrine Tumors (NETs)

Active substance: Gallium (68Ga) edotreotide


Patient Information / Patienteninformation:

Package Leaflet

Gebrauchsinformation DE

Gebrauchsinformation AT

Marketing authorization in Austria under the brand name Sogacin® / Marktzulassung in Österreich unter dem Markennamen Sogacin®


Additional information for Healthcare Professionals

Marketing Authorization Holder:
ITM Medical Isotopes GmbH. A company of the ITM Group.

Please contact our Sales Team, if you need any further information:
Email: RadiopharmaOperations(at)
Phone: +49 89 329 8986 6000